Brouwer Roald 4
Research Summary
AI-generated summary
Amrize (AMRZ) CTO Roald Brouwer Receives 4,257-Share Award
What Happened
Roald Brouwer, Chief Technology Officer of Amrize Ltd (AMRZ), received 4,257 ordinary shares on February 27, 2026. The shares were issued at $0.00 as the settlement of performance stock units (PSUs) converted into Amrize shares; the reported acquisition value is $0. This was a grant/settlement of equity awards, not an open-market purchase or sale.
Key Details
- Transaction date and price: 2026-02-27; 4,257 shares at $0.00 per share (total reported value $0).
- Shares owned after transaction: not disclosed in the filing.
- Footnote: The shares represent settlement of PSUs that resulted from conversion of equity awards previously granted by Holcim Ltd, converted in connection with Amrize’s June 23, 2025 spin-off; the PSUs vested based on Holcim and Amrize performance for Jan 1, 2023–Dec 31, 2025.
- Filing timeliness: Form 4 was filed on 2026-03-03 and appears timely (filed within the required two business days after the Feb 27 transaction).
Context
This transaction reflects the administrative settlement of performance-based equity tied to prior Holcim awards and the company spin-off, not a market purchase or sale. Such awarded shares provide equity alignment with management but do not, by themselves, indicate a buy/sell market signal.